Leafly Transitions To OTC After NASDAQ Delisting
The company failed to achieve the necessary minimum net income of $500,000 from operations, to retain listing on the NASDAQ.
Words by Damian Nicholas
NASDAQ MARKETSITE / GETTY IMAGES
Leafly Holdings, a prominent player in the marijuana e-commerce sector, is set to be delisted from the Nasdaq stock market on January 17. This decision follows a ruling by the exchange’s hearings panel, which concluded that Leafly failed to achieve the necessary minimum net income of $500,000 from operations. The announcement marks a significant shift for the company, which has been navigating the complexities of the cannabis industry in both Canada and Germany.
For reference, net income for a company, is the amount of money an organization has left after all expenses, taxes, and costs have been subtracted from total revenue. In business lingo, this is referred to as your "bottom line". For Leafly, this is a key measure for an investor to determine company profitability, as it represents the profit available for reinvestment, dividends, or savings.
ADVERTISEMENT
In light of the delisting, Leafly will transition its shares to the OTC Pink Open Market. Once this transfer occurs, the company’s stock will be traded under the ticker symbols LFLY and LFLYW. Moving to the OTC Pink Market typically presents challenges that could impact the company's future operations. According to an analysis by Stock Titan, which assists stock traders and investors, this transition may lead to lower liquidity levels, decreased interest from institutional investors, and additional hurdles when raising capital. Such factors can significantly affect a company’s growth trajectory, making it crucial for Leafly to address these challenges proactively.
In response to the current financial situation, Leafly also announced that it has successfully negotiated with the holders of its 8% convertible senior notes. As part of this agreement, the maturity date for the notes has been extended from January 31 to July 1. The company plans to repay 12.5% of the principal amount and any accrued interest on the notes by January 21, providing some financial relief during this transitional phase.
LEAFLY
Despite these efforts, it’s important to note that this is not the first instance of Leafly grappling with compliance issues related to Nasdaq regulations. The cannabis industry as a whole has faced scrutiny and regulatory challenges that can complicate the path for companies within it. Stakeholders and investors are keenly watching how Leafly will navigate its current circumstances, especially as it seeks to maintain stability and regain growth momentum.
As the cannabis market continues to evolve, the implications of Leafly's delisting and transition to the OTC market will be pivotal in shaping the company’s prospects. Investors will need to closely monitor how these changes impact Leafly's operations, market presence, and overall financial health in the coming months.
Damian Nicholas
Editor-in-Chief, Frasspot
Damian Nicholas is editor-in-chief for Frasspot. He manage all content, production, and consumer experiences across all platforms. He has contributed as editor-in-chief since December 2019.
Jan 22, 2025
More in Journal
Journal Herb Report: California Cannabis Cultivators Anticipate 2024 as Record Harvest Year Amid Expected Market Stabilization
ADVERTISEMENT
Trending